Kenalog-10 Interactions
There are 618 drugs known to interact with Kenalog-10 (triamcinolone), along with 23 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 107 are major, 476 are moderate, and 35 are minor.
- View all 618 medications that may interact with Kenalog-10
- View Kenalog-10 alcohol/food interactions (2)
- View Kenalog-10 disease interactions (23)
Most frequently checked interactions
View interaction reports for Kenalog-10 (triamcinolone) and the medicines listed below.
- acetaminophen
- amoxicillin
- aspirin
- baclofen
- Benadryl (diphenhydramine)
- benzonatate
- cyclobenzaprine
- Cymbalta (duloxetine)
- doxycycline
- famotidine
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- ibuprofen
- levothyroxine
- lisinopril
- losartan
- magnesium oxide
- meclizine
- melatonin
- meloxicam
- metformin
- omeprazole
- pantoprazole
- prednisone
- tramadol
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
- Zyrtec (cetirizine)
Kenalog-10 alcohol/food interactions
There are 2 alcohol/food interactions with Kenalog-10 (triamcinolone).
Kenalog-10 disease interactions
There are 23 disease interactions with Kenalog-10 (triamcinolone) which include:
- infections
- prematurity
- (+) tuberculin test
- cirrhosis
- depression/psychoses
- diabetes
- electrolyte imbalance
- fluid retention
- GI perforation
- hyperadrenocorticalism
- hyperlipidemia
- hypothyroidism
- liver disease
- MI
- myasthenia gravis
- myopathy
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- PUD
- scleroderma
- strongyloidiasis
- thromboembolism
Report options
More about Kenalog-10 (triamcinolone)
- Compare alternatives
- Pricing & coupons
- Reviews (23)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: glucocorticoids
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Saphnelo
Saphnelo is used for moderate to severe SLE (lupus) for adults who are also receiving other lupus ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Benlysta
Benlysta is used to treat active systemic lupus erythematosus (SLE) and active lupus nephritis. It ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Ilumya
Ilumya (tildrakizumab) is used to treat moderate-to-severe plaque psoriasis to reduce plaques ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Methylprednisolone
Methylprednisolone is used to treat conditions such as allergies, arthritis, lupus and ulcerative ...
Diclofenac
Diclofenac is a nonsteroidal anti-inflammatory drug used to treat pain and inflammation associated ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.